Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Triumph Expands Intelligence Offering for Brokers to Include Pricing, Performance and Capacity
-
Achieve Life Sciences Announces Publication in Thorax of Data Demonstrating Cytisinicline’s Potential Efficacy and Tolerability for Smoking Cessation in Individuals with COPD
-
CRISPR Therapeutics and Sirius Therapeutics Announce First Patient Dosed in Phase 2 Trial of SRSD107 for Thromboembolic Disorders in Europe
-
NetraMark Initiates AI-Driven Collaboration in Glioblastoma Research
-
Beyond Oil Appoints Michael Nemirow as President, North America
-
OKYO Pharma Announces Registration Pathway with 100 Patient Multi-Center Clinical Trial of Urcosimod in Neuropathic Corneal Pain
-
Heritage Distilling Rebrands as IP Strategy, Announces Ticker Change to IPST and Reports Special Stockholder Meeting Results
-
YY Group Announces Strategic Expansions Into Netherlands, Strengthening its EU Presence
-
Integra LifeSciences Strengthens Leadership with Appointment of New Chief Medical Officer
-
Chaince Securities LLC Serves as Exclusive Placement Agent in Wellchange Holdings’ (NASDAQ: WCT) $4 Million Private Placement
-
Hubject Teams with Blink Charging to Further Expand Intercharge Network Across North America
-
Weatherford Announces Tender Offer for up to $700 Million of Senior Notes due 2030
-
Jushi Holdings Inc. Announces Favorable Modifications to Existing Manassas, VA Mortgage
-
Weatherford Announces Private Offering of $600 Million of Senior Notes due 2033
-
FOXO TECHNOLOGIES INC. ANNOUNCES CLOSING OF VECTOR BIOSOURCE INC. ACQUISITION
-
New Peer Reviewed Publication of Combination Therapy in Vitiligo with STRATA Skin Sciences’ Excimer Laser and JAK Inhibitors Demonstrated Superior Safety and Unprecedented Response Rates, Providing
-
Strive, Inc. (Nasdaq: ASST) and Semler Scientific, Inc. (Nasdaq: SMLR) Announce Bitcoin Treasury Merger in All-Stock Transaction
-
Aivista Quant Capital Launches Caelus AI and AQC Token Ecosystem, Ushering in a New Era of Intelligent Investing
-
ECD Automotive Design Granted Continued Listing by the Nasdaq Hearings Panel
-
24/7 Market News: Kraig Labs Targets Eco Luxury Spider Silk Apparel Market
-
AMN Healthcare Launches $400.0 Million Offering of Senior Notes
-
IMUNON Presents IMNN-001 Phase 2 Translational Data in Advanced Ovarian Cancer Demonstrating 13-Month OS Extension via Tumor Micro-Environment Shift
-
Blaze Pizza Ignites in Linden, New Jersey With Free Pizza Day Grand Opening Celebration on September 30
-
Cosmos Health Commences U.S. Operations, Entering $164B Nutraceuticals Market with Its Sky Premium Life Brand; Expects 75% Gross Margins and Strong Cash Flow, with NOOR Collagen Alone Projected to Gen
-
Lerøy Seafood Group ASA: Green Bond Mandate Announcement
-
Schouw & Co. share buy-back programme, week 38 2025
-
Allarity Therapeutics Presents New Phase 2 Clinical Data for Stenoparib/2X-121 Showing Landmark Median Overall Survival Has Now Surpassed 25 Months
-
Announcement by Embraer S.A. of Offers to Purchase for Cash Certain Outstanding Securities Listed Below
-
Medtech Leader Erica Rogers Joins Ceribell Board of Directors
-
Lancaster Resources Secures District-Scale Expansion, Doubling Footprint at Lake Cargelligo Gold Project to 62,300 hectares
-
Aventis Energy Confirms Strong Radioactivity During Successful Exploration Program at the Corvo Uranium Project
-
LGI Homes Returns to Rio Rancho, NM, with the Grand Opening of Estrella at High Range
-
Adverum Biotechnologies Announces Completion of Screening for Pivotal Phase 3 ARTEMIS Trial of Ixo-vec for Wet Age-Related Macular Degeneration
-
Connect Names Gretel von Son as Chief Operating Officer to Drive Growth in Entrepreneurship and Innovation
-
ORYZON to Sponsor First Phelan-McDermid Syndrome (PMS) Burden of Illness Study
-
Picard Advances Patent Protection for Fully Implantable Artificial Heart Technology
-
Cerevance to Present Phase 2 Data on Solengepras in Parkinson’s Disease at the 2025 International Congress of Parkinson's Disease and Movement Disorders
-
IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Vuong Trieu, CEO of Oncotelic Therapeutics Inc.
-
Advent Technologies Delivers State-of-the-Art Portable Fuel Cell Systems under Contract with the U.S. Department of Defense
-
Grace Therapeutics Pivotal Phase 3 STRIVE-ON Safety Trial Presented at 2025 Neurocritical Care Annual Meeting
-
Idebenone Accepted by FDA for Priority Review for Leber Hereditary Optic Neuropathy (LHON)
-
Beyond Air to Participate in the ROTH 4th Annual Healthcare Opportunities Conference
-
LifeVantage to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
-
Kratos Defense & Security Solutions to Join S&P MidCap 400 Index
-
electroCore’s Truvaga™ Plus Named “Best Relaxation Gadget” in Esquire’s 2025 Sleep Awards
-
Blue Sky Planners Launches a Gift-Worthy Collection with Morris & Co.
-
BioCardia Announces Positive Preliminary Clinical Consultation with Japan Pharmaceutical and Medical Device Agency on Cell Therapy for Ischemic Heart Failure
-
Corbus Pharmaceuticals to Host In-Person and Virtual KOL Event at ESMO 2025
-
CEA Industries Board Authorizes $250 Million Stock Buyback Program
-
Onconetix announces its subsidiary, Proteomedix, licenses manufacturing IP to Immunovia enabling them to independently produce key reagents for their pancreatic cancer test PancreaSureTM
